IBDEI144 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19630,0)
 ;;=042.^^105^1233^25
 ;;^UTILITY(U,$J,358.3,19630,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19630,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,19630,1,5,0)
 ;;=5^HIV Disease (symptomatic)
 ;;^UTILITY(U,$J,358.3,19630,2)
 ;;=HIV Disease (symptomatic)^266500
 ;;^UTILITY(U,$J,358.3,19631,0)
 ;;=464.00^^105^1233^2
 ;;^UTILITY(U,$J,358.3,19631,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19631,1,4,0)
 ;;=4^464.00
 ;;^UTILITY(U,$J,358.3,19631,1,5,0)
 ;;=5^Acute Laryngitis
 ;;^UTILITY(U,$J,358.3,19631,2)
 ;;=Acute Laryngitis^323469
 ;;^UTILITY(U,$J,358.3,19632,0)
 ;;=790.6^^105^1233^1
 ;;^UTILITY(U,$J,358.3,19632,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19632,1,4,0)
 ;;=4^790.6
 ;;^UTILITY(U,$J,358.3,19632,1,5,0)
 ;;=5^Abnormal LFT's
 ;;^UTILITY(U,$J,358.3,19632,2)
 ;;=^87228
 ;;^UTILITY(U,$J,358.3,19633,0)
 ;;=780.60^^105^1233^20
 ;;^UTILITY(U,$J,358.3,19633,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19633,1,4,0)
 ;;=4^780.60
 ;;^UTILITY(U,$J,358.3,19633,1,5,0)
 ;;=5^Fever
 ;;^UTILITY(U,$J,358.3,19633,2)
 ;;=^336764
 ;;^UTILITY(U,$J,358.3,19634,0)
 ;;=795.51^^105^1233^55
 ;;^UTILITY(U,$J,358.3,19634,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19634,1,4,0)
 ;;=4^795.51
 ;;^UTILITY(U,$J,358.3,19634,1,5,0)
 ;;=5^Pos PPD w/o Active TB
 ;;^UTILITY(U,$J,358.3,19634,2)
 ;;=^340572
 ;;^UTILITY(U,$J,358.3,19635,0)
 ;;=482.9^^105^1233^53
 ;;^UTILITY(U,$J,358.3,19635,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19635,1,4,0)
 ;;=4^482.9
 ;;^UTILITY(U,$J,358.3,19635,1,5,0)
 ;;=5^Pneumonia,Bacterial
 ;;^UTILITY(U,$J,358.3,19635,2)
 ;;=^12347
 ;;^UTILITY(U,$J,358.3,19636,0)
 ;;=571.42^^105^1233^31
 ;;^UTILITY(U,$J,358.3,19636,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19636,1,4,0)
 ;;=4^571.42
 ;;^UTILITY(U,$J,358.3,19636,1,5,0)
 ;;=5^Hepatitis, Autoimunne
 ;;^UTILITY(U,$J,358.3,19636,2)
 ;;=^336610
 ;;^UTILITY(U,$J,358.3,19637,0)
 ;;=795.52^^105^1233^54
 ;;^UTILITY(U,$J,358.3,19637,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19637,1,4,0)
 ;;=4^795.52
 ;;^UTILITY(U,$J,358.3,19637,1,5,0)
 ;;=5^Pos GMA Interferon w/o Active TB
 ;;^UTILITY(U,$J,358.3,19637,2)
 ;;=^340573
 ;;^UTILITY(U,$J,358.3,19638,0)
 ;;=682.0^^105^1234^6
 ;;^UTILITY(U,$J,358.3,19638,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19638,1,4,0)
 ;;=4^682.0
 ;;^UTILITY(U,$J,358.3,19638,1,5,0)
 ;;=5^Cellulitis Of Face
 ;;^UTILITY(U,$J,358.3,19638,2)
 ;;=^271888
 ;;^UTILITY(U,$J,358.3,19639,0)
 ;;=681.00^^105^1234^7
 ;;^UTILITY(U,$J,358.3,19639,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19639,1,4,0)
 ;;=4^681.00
 ;;^UTILITY(U,$J,358.3,19639,1,5,0)
 ;;=5^Cellulitis Of Finger NOS
 ;;^UTILITY(U,$J,358.3,19639,2)
 ;;=^271883
 ;;^UTILITY(U,$J,358.3,19640,0)
 ;;=682.7^^105^1234^8
 ;;^UTILITY(U,$J,358.3,19640,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19640,1,4,0)
 ;;=4^682.7
 ;;^UTILITY(U,$J,358.3,19640,1,5,0)
 ;;=5^Cellulitis Of Foot
 ;;^UTILITY(U,$J,358.3,19640,2)
 ;;=^271895
 ;;^UTILITY(U,$J,358.3,19641,0)
 ;;=682.4^^105^1234^9
 ;;^UTILITY(U,$J,358.3,19641,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19641,1,4,0)
 ;;=4^682.4
 ;;^UTILITY(U,$J,358.3,19641,1,5,0)
 ;;=5^Cellulitis Of Hand
 ;;^UTILITY(U,$J,358.3,19641,2)
 ;;=^271892
 ;;^UTILITY(U,$J,358.3,19642,0)
 ;;=682.6^^105^1234^10
 ;;^UTILITY(U,$J,358.3,19642,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19642,1,4,0)
 ;;=4^682.6
 ;;^UTILITY(U,$J,358.3,19642,1,5,0)
 ;;=5^Cellulitis Of Leg
 ;;^UTILITY(U,$J,358.3,19642,2)
 ;;=^271894
 ;;^UTILITY(U,$J,358.3,19643,0)
 ;;=682.1^^105^1234^11
 ;;^UTILITY(U,$J,358.3,19643,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19643,1,4,0)
 ;;=4^682.1
 ;;
 ;;$END ROU IBDEI144
